Novel complication of nusinersen treatment: Hyponatremia

Creative Commons License

Coban Y., Aslan N., Yildizdas D., ÖZGÜR HOROZ Ö., GÜL MERT G.

NEUROLOGY ASIA, cilt.25, sa.1, ss.85-86, 2020 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.29328/journal.jcicm.1001014
  • Dergi Adı: NEUROLOGY ASIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Sayfa Sayıları: ss.85-86
  • Çukurova Üniversitesi Adresli: Evet

Özet

Nusinersen is a novel therapy for spinal muscular atrophy (SMA) type 1. Thus, the adverse reactions of the therapy have not been well established. We present here a 5-months old boy with SMA type 1, who developed hyponatremia after a single dose of nursinersen which has been rarely reported previously.